The combination oral and nutritional treatment of late‐onset diabetes mellitus (CONTROL DM) trial results

Objective  To examine the effect of short‐term improvements in glycaemic control on brachial artery endothelial function as a marker of cardiovascular health.

[1]  R. Moses.  Repaglinide in combination therapy with metformin in Type 2 diabetes , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  Peter Libby,et al.  Vascular biology of atherosclerosis: overview and state of the art. , 2003, The American journal of cardiology.

[3]  A. Baron,et al.  Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome. , 2003, The Journal of clinical endocrinology and metabolism.

[4]  P. Ganz,et al.  Endothelial function. From vascular biology to clinical applications. , 2002, The American journal of cardiology.

[5]  P. Ridker,et al.  Do atherosclerosis and type 2 diabetes share a common inflammatory basis? , 2002, European heart journal.

[6]  Robert M. Anderson,et al.  Prevention or delay of type 2 diabetes. , 2004, Diabetes care.

[7]  MasayoshiHashimoto,et al.  Cerivastatin, a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor, Improves Endothelial Function in Elderly Diabetic Patients Within 3 Days , 2002 .

[8]  Masayoshi Hashimoto,et al.  Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days , 2002 .

[9]  P. Holvoet,et al.  Oxidized LDL and HDL: antagonists in atherothrombosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  W. Riley,et al.  Brachial Flow-Mediated Vasodilator Responses in Population-Based Research: Methods, Reproducibility and Effects of Age, Gender and Baseline Diameter , 2001, Journal of cardiovascular risk.

[11]  M. Kipnes,et al.  Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. , 2001, The American journal of medicine.

[12]  J. Chiasson,et al.  The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes. , 2001, Diabetes care.

[13]  K. Mather,et al.  Improved endothelial function with metformin in type 2 diabetes mellitus. , 2001, Journal of the American College of Cardiology.

[14]  L Fan,et al.  An adaptive template-matching method and its application to the boundary detection of brachial artery ultrasound scans. , 2001, Ultrasound in medicine & biology.

[15]  I. Goldberg.  Diabetic Dyslipidemia: Causes and Consequences , 2001 .

[16]  E. Horton,et al.  Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. , 2000, Diabetes care.

[17]  P. Raskin,et al.  Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes. , 2000, Diabetes care.

[18]  S. Jackson,et al.  Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. , 2000, Circulation.

[19]  J. Rosenstock,et al.  Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial. , 2000, JAMA.

[20]  C. Sartori,et al.  Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. , 2000, European Journal of Endocrinology.

[21]  A. Melidonis,et al.  The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients , 2000, Clinical cardiology.

[22]  Matthew D. Davis,et al.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.

[23]  K. Kugiyama,et al.  Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. , 1999, Journal of the American College of Cardiology.

[24]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[25]  W. Riley,et al.  Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease. , 1999, Journal of the American College of Cardiology.

[26]  D. Green,et al.  Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. , 1999, Journal of the American College of Cardiology.

[27]  J. Summerson,et al.  Association of gender with symptoms and complications in type II diabetes mellitus. , 1999, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[28]  J. Cockcroft,et al.  Effect of oral vitamin E (α‐tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[29]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[30]  E. Horton,et al.  Troglitazone in Combination With Sulfonylurea Restores Glycemic Control in Patients With Type 2 Diabetes , 1998, Diabetes Care.

[31]  Uk-Prospective-Diabetes-Study-Group.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.

[32]  L. Fink,et al.  Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus. , 1998, Journal of diabetes and its complications.

[33]  Farris K. Timimi,et al.  Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. , 1998, Circulation.

[34]  C. Tack,et al.  Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone , 1998, Diabetologia.

[35]  Standards of Medical Care for Patients With Diabetes Mellitus , 1998, Diabetes Care.

[36]  A. Baron,et al.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.

[37]  M. Creager,et al.  -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .

[38]  D. Celermajer,et al.  Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. , 1994, Journal of the American College of Cardiology.

[39]  M. Laakso,et al.  NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.

[40]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[41]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[42]  G. D. Johnston,et al.  Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1992, Diabetologia.

[43]  M. Harris.  Noninsulin-dependent diabetes mellitus in black and white Americans. , 1990, Diabetes/metabolism reviews.

[44]  D. Singer,et al.  Retinopathy in Older Type II Diabetics Association With Glucose Control , 1986, Diabetes.

[45]  S. Colagiuri,et al.  Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. , 1999, Diabetes care.

[46]  G. Plotnick,et al.  Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. , 1996, The American journal of cardiology.

[47]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[48]  Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. , 1995, The American journal of cardiology.

[49]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.